Your browser doesn't support javascript.
loading
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Macaulay, Valentine M; Lord, Simon; Hussain, Syed; Maroto, José Pablo; Jones, Robert Hugh; Climent, Miguel Ángel; Cook, Natalie; Lin, Chia-Chi; Wang, Shian-Shiang; Bianchini, Diletta; Bailey, Mark; Schlieker, Laura; Bogenrieder, Thomas; de Bono, Johann.
Affiliation
  • Macaulay VM; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • Lord S; Department of Oncology, University of Oxford, Oxford, UK.
  • Hussain S; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Maroto JP; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Jones RH; Velindre Cancer Centre and Cardiff University, Cardiff, UK.
  • Climent MÁ; Instituto Valenciano de Oncología (IVO), Valencia, Spain.
  • Cook N; The Christie NHS Foundation Trust and the University of Manchester, Manchester, UK.
  • Lin CC; National Taiwan University Hospital, Taipei, Taiwan.
  • Wang SS; Taichung Veterans General Hospital, Taichung, Taiwan.
  • Bianchini D; The Institute of Cancer Research, London, UK.
  • Bailey M; The Royal Marsden NHS Foundation Trust, Sutton, London, UK.
  • Schlieker L; Boehringer Ingelheim Ltd, Bracknell, Berkshire, UK.
  • Bogenrieder T; External Statistician on behalf of Boehringer Ingelheim GmbH & Co. KG, Staburo GmbH & Co. KG, Munich, Germany.
  • de Bono J; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Br J Cancer ; 129(6): 965-973, 2023 10.
Article in En | MEDLINE | ID: mdl-37537253

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials Limits: Humans / Male Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country: Country of publication: